Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

A patient with multiple sclerosis developed skin reactions after Daclizumab treatment, requiring more data on the drug's effects.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

The treatment was effective for advanced non-Hodgkin's lymphomas.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Dupilumab significantly improved a 5-year-old girl's prurigo nodularis without side effects.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Adalimumab effectively stabilized severe folliculitis decalvans, preventing further hair loss and inflammation.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Cetuximab can cause excessive eyelash growth.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Ritlecitinib is safe and may effectively treat alopecia areata.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

HuR is essential for Treg function and preventing autoimmunity.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

Blocking IL-8 can reduce skin rashes from cancer treatment.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.